Guerbet (Guerbet) Sale Of Investment : $1.1 Mil (TTM As of Dec. 2023)

View and export this data going back to 2015. Start your Free Trial

What is Guerbet Sale Of Investment?

Guerbet's sale of investment for the six months ended in Dec. 2023 was $0.5 Mil. It means Guerbet gained $0.5 Mil from selling investments. Guerbet's sale of investment for the trailing twelve months (TTM) ended in Dec. 2023 was $1.1 Mil.

Compared with last quarter ($0.6 Mil in Jun. 2023 ), Guerbet gained less money from selling investments in Dec. 2023 ($0.5 Mil).

Guerbet Sale Of Investment Historical Data

The historical data trend for Guerbet's Sale Of Investment can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Guerbet Sale Of Investment Chart

Guerbet Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Sale Of Investment

Get a 7-Day Free Trial

8.68

1.46

1.06

Guerbet Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Sale Of Investment	Get a 7-Day Free Trial															-	0.27	-0.27	0.58	0.48

Guerbet Sale Of Investment Calculation

Sale of Investments represents cash inflow on the sale of investments in securities.

Sale Of Investment for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was $1.1 Mil.

Guerbet Sale Of Investment Related Terms

Thank you for viewing the detailed overview of Guerbet's Sale Of Investment provided by GuruFocus.com. Please click on the following links to see related term pages.

Guerbet (Guerbet) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Guerbet SA (GREY:GUERF) » Definitions » Sale Of Investment

Comparable Companies

Traded in Other Exchanges

GBT:France 4G8:Germany

Address

15 rue des Vanesses, Zone Paris Nord II, Villepinte, FRA, 93420

Website

http://www.guerbet.com

Guerbet SA is a healthcare company that manufactures and markets medical imaging contrast agents destined for diagnostic purposes. Its products include medical imaging contrast products for x-ray imaging, magnetic resonance imaging, ultrasound imaging and for nuclear medicine. The company markets its products under the brand names such as Xenetix, Optiray, Oxilan, Telebrix, Lipiodol, Dotarem, Endorem, Artirem, Lumirem, and Lipiodol.